Neoadjuvant Imatinib for Locally advanced Dermatofibrosarcoma Protuberans
Objective
Study Objectives The goal of the current study is to evaluate the use of neoadjuvant imatinib therapy in a group of patients with locally advanced dermatofibrosarcoma protuberans (DFSP) and its effect on tumor size as well as long term local recurrence rates.
